CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biotechnology company developing a pipeline of regRNA-targeting therapeutics designed to upregulate gene expression with the ...
The U.S. Environmental Protection Agency on Monday banned the use of two ubiquitous cancer-causing solvents that activists have been targeting for decades.